Anxiety disorders are the most common class of psychiatric conditions in the United States, affecting roughly 40 million adults annually—yet they are among the most widely undertreated, in part because the assumption persists that anxiety is a minor condition that responds readily to available treatments. For many patients, standard first-line approaches including SSRIs, SNRIs, and benzodiazepines do not provide adequate relief, or they produce side effects significant enough to make sustained use untenable. At Vitality Psychiatric Services in Midland, TX, Tammy Vaught, APRN, CRNA, PMHNP-BC, offers a full spectrum of interventional and pharmacological approaches for patients whose anxiety has not responded to conventional care.
Why Anxiety Disorders Often Don’t Respond to Standard Treatment
Anxiety that does not respond adequately to first-line treatments is a recognized clinical challenge, though it receives less public attention than treatment-resistant depression. The category includes generalized anxiety disorder (GAD), panic disorder, and social anxiety disorder, as well as the anxiety dimension of PTSD, which frequently co-occurs with these conditions. For patients in this situation, the frustration of having tried multiple medications and therapeutic approaches without sufficient relief is compounded by the relative lack of publicly visible alternative options—a gap that Tammy Vaught has built Vitality Psychiatric Services to address.
Pharmacological treatment for anxiety disorders typically begins with SSRIs or SNRIs, which modulate serotonin and norepinephrine systems and require four to eight weeks to reach therapeutic effect. Benzodiazepines are effective for acute anxiety but carry significant risks of dependence and cognitive side effects with long-term use and are generally not appropriate as a sustained management strategy. When SSRIs and SNRIs are not sufficient, options expand to include buspirone, atypical antipsychotics, beta-blockers for situational anxiety, and, increasingly, interventional treatments like IV ketamine.
Interventional Treatments for Anxiety That Hasn’t Improved With Medication
IV Ketamine for Anxiety Disorders: What the Evidence Shows
IV ketamine has received growing attention as a potential treatment for anxiety disorders, particularly for patients with severe or treatment-resistant presentations. The evidence base is less developed than for treatment-resistant depression, but existing studies suggest that ketamine may produce rapid reductions in anxiety severity through its effects on NMDA receptors and glutamate transmission. For patients with co-occurring depression and anxiety—a common presentation—ketamine’s documented effectiveness for depression may simultaneously address the anxiety dimension. Ketamine’s use for anxiety is off-label, and results vary by individual. Tammy discusses the current state of the evidence honestly with every patient who is considering this approach.
SPRAVATO® for Patients With Co-Occurring Treatment-Resistant Depression
SPRAVATO® (esketamine nasal spray) is FDA-approved specifically for treatment-resistant depression and MDD with acute suicidal ideation or behavior. Many patients with primary anxiety disorders also carry a diagnosis of comorbid depression, and in those cases, SPRAVATO® may be an appropriate and insurance-covered treatment option. The intersection of anxiety and depression is not merely clinical coincidence—these conditions share neurobiological underpinnings, and effective treatment often needs to address both. Tammy’s evaluation process is designed to capture the full complexity of each patient’s presentation rather than treating diagnoses in isolation.
Personalized Anxiety Care at Vitality Psychiatric Services in Midland, TX
Pharmacogenomic Testing to Understand Why Past Medications Haven’t Worked
A core differentiator at Vitality Psychiatric Services is pharmacogenomic testing, which is particularly valuable for patients who have cycled through multiple anxiety medications without finding an adequate fit. The genetic testing can identify specific enzyme variations that explain why certain medications have produced either intolerable side effects or no therapeutic effect at standard doses. For a patient with severe CYP2D6 metabolizer status, for example, many commonly prescribed antidepressants may produce unexpectedly high drug levels—explaining side effect profiles that have previously been dismissed or attributed to sensitivity. This kind of biological specificity is genuinely useful in designing a rational next step.
CBT and Telepsychiatry for Anxiety Patients Across West Texas
Psychotherapy is also a central component of Vitality’s approach to anxiety disorders. Cognitive behavioral therapy (CBT) is the best-evidenced psychological treatment for anxiety and can be delivered via Tammy’s telepsychiatry platform for patients across West Texas who cannot easily travel to Midland. For patients with severe anxiety who have found that the demands of therapy are themselves anxiety-provoking, a combination approach—using pharmacological or interventional treatment to reduce acute symptom severity first—may create conditions under which therapeutic work becomes more accessible.
Addressing Common Barriers to Interventional Anxiety Treatment
A barrier that many patients with anxiety disorders describe is the dismissive response they have received from providers who do not specialize in complex psychiatric presentations. Anxiety is real, it is disabling, and it deserves the same clinical seriousness as any other chronic medical condition. Tammy approaches every patient’s history with the assumption that if standard treatments have not worked, there is a clinical reason worth investigating—not a personal failing on the patient’s part.
The second barrier is the concern that seeking out interventional psychiatry represents an extreme step that is not yet warranted. We want to be direct: interventional options are not reserved for only the most catastrophically ill patients. They are appropriate for anyone who has not found adequate relief through conventional approaches and who is looking for something more effective. Discuss with your provider what your history of treatment responses suggests about the next appropriate step, and let that conversation happen with access to the full picture of what is available. Our post on how fast ketamine works for anxiety provides a useful overview of what patients can realistically expect from this approach.
Results vary by individual, and no treatment approach guarantees relief from anxiety. What we can offer is a genuinely thorough evaluation, a clinical relationship built on honesty, and a breadth of treatment options that is not available in most Midland-Odessa clinical practices.
Frequently Asked Questions About Anxiety Treatment in Midland, TX
Can IV ketamine help with anxiety?
Emerging clinical research suggests that IV ketamine may reduce anxiety severity in some patients, particularly those with co-occurring depression. The evidence base is growing but less established than for treatment-resistant depression. Results vary by individual, and ketamine’s use for anxiety is off-label. A thorough evaluation will help determine whether this approach is appropriate for your specific presentation.
Is SPRAVATO® an option for anxiety disorders?
SPRAVATO® is FDA-approved for treatment-resistant depression and MDD with ASIB—not directly for anxiety disorders. However, many patients with anxiety also have comorbid treatment-resistant depression, which may qualify them for SPRAVATO®. Tammy evaluates the full psychiatric picture before determining whether SPRAVATO® is appropriate.
How does pharmacogenomic testing help with anxiety treatment?
Pharmacogenomic testing identifies genetic variations that affect how your body metabolizes medications commonly used for anxiety. This can explain why certain medications have produced side effects or been ineffective, and helps guide the selection of medications more likely to be well-tolerated and effective for your biology.
Can I receive anxiety treatment via telepsychiatry?
Yes. Medication management and psychotherapy for anxiety disorders can be conducted through Tammy’s telepsychiatry platform. IV ketamine infusions require in-person visits to the Midland clinic.
What should I bring to my first appointment?
We recommend bringing documentation of any prior psychiatric diagnoses, a list of current and past medications with approximate dates of use and dosages if known, and any records from prior providers that describe previous treatment responses. The more history we have at the start, the more useful the first evaluation can be.
Key Takeaways
- Anxiety disorders affect millions of Americans and are widely undertreated, particularly in patients whose symptoms do not respond to first-line SSRIs and SNRIs
- IV ketamine may produce rapid anxiety reduction in some patients, particularly those with co-occurring depression, though its use for anxiety is off-label and results vary by individual
- SPRAVATO® is an option for patients with co-occurring treatment-resistant depression and may be covered by major insurance plans
- Pharmacogenomic testing at Vitality Psychiatric Services can help explain why past medications have not worked and guide more targeted prescribing
- Tammy Vaught’s telepsychiatry services extend access to expert anxiety treatment across West Texas without requiring every appointment to be in person
Conclusion
Persistent anxiety that has not responded to multiple medications and therapy approaches is not a permanent condition—it is an unresolved clinical problem that deserves a more thorough investigation. Tammy Vaught at Vitality Psychiatric Services in Midland has the credentials, the tools, and the commitment to bring that investigation to patients across the Permian Basin. If you are ready to explore what options exist beyond what you have already tried, please schedule a comprehensive evaluation. A better path forward may be closer than you think.
References
Anxiety and Depression Association of America — https://adaa.org/understanding-anxiety
National Institute of Mental Health — https://www.nimh.nih.gov/health/topics/anxiety-disorders
American Psychiatric Association — https://www.psychiatry.org/patients-families/anxiety-disorders
National Institutes of Health (PubMed) — https://pubmed.ncbi.nlm.nih.gov/
Harvard Health Publishing — https://www.health.harvard.edu/mind-and-mood/anxiety-and-physical-illness
About Tammy Vaught
Tammy Vaught, APRN, CRNA, PMHNP-BC, is the lead provider at Vitality Psychiatric Services in Midland, TX, where her triple certification—as an Advanced Practice Registered Nurse, Certified Registered Nurse Anesthetist, and Psychiatric Mental Health Nurse Practitioner—positions her to offer both the medication management precision and the anesthetic safety expertise that advanced psychiatric treatments require. Vitality offers a full spectrum of interventional options for treatment-resistant depression, including SPRAVATO® (FDA-approved and covered by major insurance including Aetna, BCBS, Cigna, and United), IV ketamine, and pharmacogenomic testing to identify the most appropriate medication pathways for each patient. Her approach begins with a thorough clinical evaluation and a commitment to honest assessment of what treatment is—and is not—appropriate for each individual.
Medical Disclaimer
This content is provided for educational purposes only and does not constitute medical advice. The information presented here is not intended to diagnose, treat, cure, or prevent any medical condition. Results vary by individual, and the effectiveness of any treatment depends on a wide range of personal health factors. Always discuss with your provider whether any treatment described is appropriate for your specific situation before making any healthcare decisions.